Xin Zeng Selected Research

Carcinogenesis

6/2021	The DNA replication regulator MCM6: An emerging cancer biomarker and target.
1/2021	PD-1 blockade prevents the progression of oral carcinogenesis.
1/2021	Adrenergic Blockade by Nebivolol to Suppress Oral Squamous Cell Carcinoma Growth via Endoplasmic Reticulum Stress and Mitochondria Dysfunction.
1/2020	The significance of PA28γ and U2AF1 in oral mucosal carcinogenesis.
10/2018	Screening diagnostic biomarkers of OSCC via an LCM-based proteomic approach.
1/2016	Interleukin-37 expression and its potential role in oral leukoplakia and oral squamous cell carcinoma.
11/2010	Roles of tetrahydrobiopterin in promoting tumor angiogenesis.
1/2010	Oral cancer overexpressed 1 (ORAOV1) regulates cell cycle and apoptosis in cervical cancer HeLa cells.
11/2008	Differentiation therapy of hepatocellular carcinoma in mice with recombinant adenovirus carrying hepatocyte nuclear factor-4alpha gene.
8/2003	[The relationship of Fas and Fas L protein expression in oral carcinogenesis].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xin Zeng Research Topics

Disease

72	Neoplasms (Cancer) 09/2022 - 11/2008
26	Squamous Cell Carcinoma of Head and Neck 06/2022 - 02/2012
22	Infections 09/2022 - 06/2010
15	Inflammation (Inflammations) 04/2022 - 07/2011
15	Oral Lichen Planus 11/2020 - 06/2008
10	Carcinogenesis 06/2021 - 08/2003
9	Fibrosis (Cirrhosis) 01/2022 - 08/2005
8	Neoplasm Metastasis (Metastasis) 06/2022 - 10/2017
8	Mouth Neoplasms (Oral Cancer) 04/2022 - 09/2009
8	Breast Neoplasms (Breast Cancer) 01/2021 - 08/2014
7	Oral Leukoplakia 09/2022 - 08/2009
7	Non-alcoholic Fatty Liver Disease 12/2021 - 03/2006
7	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 11/2008
6	Insulin Resistance 01/2022 - 07/2016
6	Pain (Aches) 01/2022 - 10/2006
6	Liver Cirrhosis (Hepatic Cirrhosis) 02/2021 - 06/2009
4	Ulcer 06/2022 - 05/2009
4	Colorectal Neoplasms (Colorectal Cancer) 12/2021 - 01/2015
4	Carcinoma (Carcinomatosis) 01/2020 - 10/2010
4	Angiostrongyliasis 06/2015 - 03/2013
3	Bacterial Infections (Bacterial Infection) 09/2022 - 01/2018
3	Leukoplakia 09/2022 - 02/2019
3	Renal Cell Carcinoma (Grawitz Tumor) 09/2022 - 08/2017
3	Vulvovaginal Candidiasis 05/2022 - 01/2018
3	Body Weight (Weight, Body) 01/2022 - 03/2013
3	Oral Candidiasis (Thrush) 01/2022 - 10/2010
3	Cardiovascular Diseases (Cardiovascular Disease) 08/2021 - 03/2012
3	Prostatic Neoplasms (Prostate Cancer) 05/2021 - 01/2019
3	Stomatitis 01/2021 - 10/2010
3	Obesity 01/2021 - 01/2020
3	Lung Neoplasms (Lung Cancer) 01/2021 - 01/2019
3	Mitochondrial Diseases (Mitochondrial Disease) 01/2021 - 08/2020
3	Mitral Valve Insufficiency (Mitral Regurgitation) 01/2021 - 02/2015
3	Alcoholic Fatty Liver 01/2020 - 04/2011
3	HIV Infections (HIV Infection) 01/2018 - 03/2015
3	Wounds and Injuries (Trauma) 01/2018 - 11/2005
3	Demyelinating Diseases (Demyelinating Disease) 01/2018 - 07/2014
3	Cardiotoxicity 08/2017 - 04/2016
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2017 - 01/2010
3	Oral Submucous Fibrosis 09/2016 - 10/2010
3	Shock 11/2015 - 01/2009

Drug/Important Bio-Agent (IBA)

24	Proteins (Proteins, Gene)FDA Link 02/2022 - 08/2003
22	Pharmaceutical PreparationsIBA 09/2022 - 03/2013
19	Biomarkers (Surrogate Marker)IBA 04/2022 - 08/2005
14	CytokinesIBA 01/2021 - 06/2008
11	MicroRNAs (MicroRNA)IBA 06/2022 - 01/2014
8	InterleukinsIBA 01/2021 - 04/2012
7	Messenger RNA (mRNA)IBA 01/2022 - 03/2013
6	Anti-Bacterial Agents (Antibiotics)IBA 09/2022 - 03/2015
6	Insulin (Novolin)FDA Link 01/2022 - 01/2016
6	Biological ProductsIBA 01/2021 - 03/2010
5	TeaIBA 01/2021 - 07/2011
5	EnzymesIBA 04/2020 - 06/2010
5	Interleukin-10 (Interleukin 10)IBA 01/2019 - 07/2009
5	Interleukin-4 (Interleukin 4)IBA 01/2019 - 06/2008
5	InterferonsIBA 01/2019 - 10/2012
5	Transcription Factors (Transcription Factor)IBA 01/2017 - 11/2008
4	RNA (Ribonucleic Acid)IBA 06/2022 - 02/2016
4	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2016
4	Hematoxylin (Haematoxylon)IBA 01/2022 - 11/2005
4	Eosine Yellowish-(YS) (Eosin)IBA 01/2022 - 11/2005
4	CollagenIBA 01/2022 - 08/2005
4	AcidsIBA 12/2021 - 06/2015
4	Long Noncoding RNAIBA 05/2021 - 06/2014
4	Small Interfering RNA (siRNA)IBA 02/2021 - 11/2006
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 02/2012
4	Glutathione (Reduced Glutathione)IBA 01/2020 - 08/2014
4	Albendazole (Albenza)FDA Link 10/2016 - 03/2013
4	DNA (Deoxyribonucleic Acid)IBA 10/2015 - 10/2012
4	Therapeutic UsesIBA 07/2014 - 03/2006
3	1-phenyl-3,3-dimethyltriazene (PDT)IBA 09/2022 - 06/2021
3	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2022 - 01/2019
3	IntegrinsIBA 01/2022 - 01/2014
3	LycopeneIBA 01/2022 - 10/2010
3	Nitric Oxide DonorsIBA 05/2021 - 08/2017
3	Neuroprotective AgentsIBA 01/2021 - 07/2014
3	Monoclonal AntibodiesIBA 01/2021 - 04/2017
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 07/2009
3	CateninsIBA 08/2020 - 10/2013
3	SteroidsIBA 03/2020 - 10/2010
3	AntigensIBA 07/2018 - 07/2017
3	Interleukin-17 (Interleukin 17)IBA 01/2018 - 06/2013
3	PolymersIBA 01/2018 - 05/2013
3	Carbon Tetrachloride (Tetrachloromethane)IBA 01/2016 - 11/2006
3	Interleukin-5 (Interleukin 5)IBA 06/2015 - 03/2013
3	ChemokinesIBA 06/2015 - 02/2014
3	GoldIBA 02/2015 - 08/2014
3	sophocarpineIBA 02/2015 - 04/2011
3	Dexamethasone (Maxidex)FDA LinkGeneric 11/2014 - 05/2012
3	amlexanox (Aphthasol)FDA Link 05/2012 - 10/2006
2	Photosensitizing Agents (Photosensitizers)IBA 09/2022 - 04/2022

Therapy/Procedure

30	Therapeutics 09/2022 - 11/2008
9	Drug Therapy (Chemotherapy) 10/2020 - 10/2010
5	Photochemotherapy (Photodynamic Therapy) 09/2022 - 11/2020
4	Lasers (Laser) 09/2022 - 02/2019
4	Oral Medicine 07/2021 - 03/2010
4	Radiotherapy 01/2021 - 10/2010
4	Aftercare (After-Treatment) 10/2019 - 03/2012
3	Injections 01/2021 - 04/2016
3	Immunotherapy 01/2021 - 01/2019